• Immunovia plans to issue up to 1,057,047,973 warrants of series TO 4 through a rights issue raising approximately SEK 63.4 million.
• Each unit costs SEK 0.06, comprising two shares and one warrant of series TO 4 issued free of charge.
• Subscriptions run November 9-23, 2026; subscription undertakings and a bottom guarantee commitment cover approximately 78.8% of the rights issue.
• Each warrant entitles holders to subscribe for one new share at SEK 0.03 from April 19 through May 3, 2027.
• Full warrant exercise would generate additional proceeds of approximately SEK 31.7 million before issue costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovia AB published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.